CLEAR-AD U19 Scholars Program

Mayo Clinic researchers and colleagues from 13 institutions around the country are pursuing projects to identify targets for Alzheimer's disease treatment. The program seeks to identify the next generation of precision medicine biomarkers and potential novel therapeutic targets of Alzheimer's disease and related dementias.

The program, called Centrally-Linked Longitudinal Peripheral Biomarkers of AD in Multi-Ethnic Populations (CLEAR-AD), is funded by a five-year grant from the National Institute on Aging, which is part of the National Institutes of Health. The grant is expected to total $41 million. Learn more.

The two-year CLEAR-AD U19 Scholars Program is for early-career scientists from groups understudied in biomedical research. Scholars will receive an award of $25,000 a year to facilitate their participation in this program. Recent college graduates, graduate students, and postdoctoral students or clinical fellows are encouraged to apply. Early-stage faculty with an appointment at Mayo Clinic or Indiana University also are eligible.

Mayo Clinic and Indiana University will each accept one CLEAR-AD U19 Scholar per year. Scholars will have access to a rich curriculum along with formal mentorship. Scholars also will be integrated into a project and participate in program meetings.